SA, M., E, H., AM, K., C, N., FL, K., C, Y., . . . RS, H. (2022). Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2022.08.07.503099
Chicago Style (17th ed.) CitationSA, Moghadasi, et al. "Transmissible SARS-CoV-2 Variants with Resistance to Clinical Protease Inhibitors." BioRxiv : The Preprint Server for Biology 2022. https://doi.org/10.1101/2022.08.07.503099.
MLA (9th ed.) CitationSA, Moghadasi, et al. "Transmissible SARS-CoV-2 Variants with Resistance to Clinical Protease Inhibitors." BioRxiv : The Preprint Server for Biology, 2022, https://doi.org/10.1101/2022.08.07.503099.
Warning: These citations may not always be 100% accurate.